genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Neurons Grown in the Lab Strikingly Similar to Brain Cells
News
Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II…
News
CRISPR Aids Fight Against Neglected Tropical Diseases
News
Endocrine-Disrupting Chemical Found in Store Receipts
News
ALS Researchers Discover New Biomarker and Drug Target
Insights
Insights
Top 10 Global Biopharma IPOs of 2018
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
A-Lists
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Insights
Top 10 Molecular Millionaires of 2018
A-Lists
Top 10 Pharma Companies of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
News
Neurons Grown in the Lab Strikingly Similar to Brain Cells
News
Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II…
News
ALS Researchers Discover New Biomarker and Drug Target
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
Webinars
Streamlined Formulation of Enzyme Products
January 2019 Vol. 39 No. 1
American Association for the Advancement of Science
January 2019 Vol. 39 No. 1
Virtual Fly Brain
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Drug Discovery
Vaccine Development
Vaccine Development
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Vaccine Development
Utilizing External Collaboration to Accelerate Vaccine Development
Vaccine Development
Improved Humanized Mice Enhance Vaccine Development
Vaccine Development
Cancer Vaccine Kills Cancer Cells and the Cells They Dupe
Vaccine Development
Moderna Files for Largest-Ever Biotech IPO, Seeking to Raise $500M
Vaccine Development
Probiotic, Live Vaccine Both Curb Cholera
Vaccine Development
Vical Halts Development of HSV-2 Vaccine after Phase II Failure
Vaccine Development
Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership
Vaccine Development
Bavarian Nordic Wins Up-to-$36M DoD Contract toward Equine Encephalitis Vaccine
Vaccine Development
After Lead Candidate Failure, Vical Axes More Than Half Its Workforce
Vaccine Development
Universal Flu Vaccine a Nanoparticle That Is All Stalk, No Head
Vaccine Development
Personalized Dendritic Cell Vaccines Could Improve Cancer Immunotherapy
Vaccine Development
TB Vaccine Induces Innate Response via Bone Marrow Stem Cells
Vaccine Development
Opioid Abuse May Be Curbed by New Vaccine
Vaccine Development
Sanofi to Expand Seasonal Flu Vaccine Manufacturing Site
Vaccine Development
Bavarian Nordic Wins Up-to-$539M BARDA Contract for Smallpox Vaccine
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar14_2017_WikiCommons_MicroRNAAndmRNAVisualization2173942127-324x160.jpg "Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership")
![Some species of Vibrio bacteria (blue) can cause cholera in humans. A version of Vibrio cholerae designed to be harmless may one day protect people against the dangerous form of the bacteria. [Tina Carvalho/University of Hawaii at Manoa/CC BY 2.0]](https://www.genengnews.com/wp-content/uploads/2018/08/Jun14_2018_UnivHawaii_Vibrio1962072475-265x198.jpg "Probiotic, Live Vaccine Both Curb Cholera")